Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review

Francesca Reyes Domingo, Lisa A Waddell, Angela M. Cheung, Curtis L. Cooper, Veronica J. Belcourt, Alexandra M. E. Zuckermann, Tricia Corrin, Rukshanda Ahmad, Laura Boland, Claudie Laprise, Leanne Idzerda, Anam Khan, Kate Morissette, Alejandra Jaramillo Garcia
doi: https://doi.org/10.1101/2021.06.03.21258317
Francesca Reyes Domingo
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: francesca.reyes.domingo@phac-aspc.gc.ca
Lisa A Waddell
2Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela M. Cheung
3Department of Medicine, University Health Network and University of Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis L. Cooper
4Department of Medicine, University of Ottawa; Ottawa Hospital Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica J. Belcourt
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra M. E. Zuckermann
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tricia Corrin
2Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rukshanda Ahmad
5Health Professionals Guidance Unit, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Boland
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudie Laprise
6Public Health Capacity and Knowledge Management Unit, Quebec Regional Office, Public Health Agency of Canada
7Division of Oral Health and Society, Faculty of Dentistry, McGill University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leanne Idzerda
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anam Khan
5Health Professionals Guidance Unit, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Morissette
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandra Jaramillo Garcia
1Evidence Synthesis and Knowledge Translation Unit, Applied Research Division, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Post COVID-19 condition refers to persisting or recurring symptoms weeks after acute COVID-19 illness which can significantly impact quality of life and health systems. It is important to understand the manifestation and magnitude of this condition. The objective of this living systematic review is to summarize the prevalence of symptoms and sequelae reported by people ≥4 weeks after COVID-19 diagnosis.

Design Systematic review, meta-analysis and narrative synthesis.

Data sources Embase, Medline, PsychInfo, Cochrane Central and select grey literature up to April 14, 2021.

Methods We adapted a previous search strategy used by the U.K. National Institute for Health and Care Excellence and updated it to search for new literature. Two reviewers screened references independently; one extracted data and assessed risk of bias and certainty of the evidence while another verified them. Prevalence data from laboratory-confirmed populations were meta-analyzed using a random effects model and synthesized separately in the short-term (4-12 weeks) and long-term (>12 weeks) periods after diagnosis. Data from clinically-diagnosed populations were synthesized narratively.

Results Of the 4444 unique citations, 84 observational studies met our inclusion criteria. Over 100 post COVID-19 symptoms and sequelae were reported. Sixty-one percent (95% CI: 44-76%, low certainty) and 53% (95% CI: 41-65%, low certainty) of laboratory-confirmed individuals reported persistence or presence of one or more symptoms in the short- and long-term periods, respectively. The most prevalent symptoms in both periods included: fatigue, general pain or discomfort, shortness of breath, cognitive impairment and mental health symptoms.

Conclusions A substantial proportion of individuals reported a variety of symptoms ≥4 weeks after COVID-19 diagnosis. Due to gaps in the research base, and the low certainty of the evidence currently available, further research is needed to determine the true burden of post COVID-19 condition in the general population and in specific subgroups.

PROSPERO registration number CRD42021231476.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding for the conduct of this review is provided by the Public Health Agency of Canada.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approvals for the conduct of this systematic review were provided by the Public Health Agency of Canada.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding Statement: Funding for the conduct of this review is provided by the Public Health Agency of Canada.

  • Competing interests: none

  • The results have been updated to include data from studies published between January 16, 2021 to April 14, 2021 that have met the inclusion criteria for this review.

Data Availability

The data that support the findings of this study are available from the corresponding author, FRD, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review
Francesca Reyes Domingo, Lisa A Waddell, Angela M. Cheung, Curtis L. Cooper, Veronica J. Belcourt, Alexandra M. E. Zuckermann, Tricia Corrin, Rukshanda Ahmad, Laura Boland, Claudie Laprise, Leanne Idzerda, Anam Khan, Kate Morissette, Alejandra Jaramillo Garcia
medRxiv 2021.06.03.21258317; doi: https://doi.org/10.1101/2021.06.03.21258317
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review
Francesca Reyes Domingo, Lisa A Waddell, Angela M. Cheung, Curtis L. Cooper, Veronica J. Belcourt, Alexandra M. E. Zuckermann, Tricia Corrin, Rukshanda Ahmad, Laura Boland, Claudie Laprise, Leanne Idzerda, Anam Khan, Kate Morissette, Alejandra Jaramillo Garcia
medRxiv 2021.06.03.21258317; doi: https://doi.org/10.1101/2021.06.03.21258317

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (415)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1750)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10301)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1769)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)